Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boryung DTaP-IPV
- Development stage
- Unknown
- Lead developer
- Boryung Biopharma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Boryung DTaP-IPV is a combination vaccine developed by Boryung Biopharma for the active immunization of infants and children against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). The vaccine is a biological product containing diphtheria toxoid, tetanus toxoid, acellular pertussis antigens derived from *Bordetella pertussis*, and inactivated poliovirus. It functions by inducing protective antibody-mediated immunity against the four target pathogens. Administered via intramuscular injection, it is typically used in a primary vaccination series at 2, 4, and 6 months of age, followed by a booster dose between 4 and 6 years of age. The product is available in a prefilled syringe formulation and is an integral part of the National Immunization Program in South Korea.
- Brand names
- Boryung DTaP-IPV
- Other names
- DTaP-IPV
02
Targets
Diphtheria toxinTT (Tetanus toxoid)
Beyond the preview
Go deeper on Boryung DTaP-IPV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boryung DTaP-IPV.